Skip to main content
Pakistan Journal of Medical Sciences logoLink to Pakistan Journal of Medical Sciences
. 2019 May-Jun;35(3):591–597. doi: 10.12669/pjms.35.3.7

Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar

Arshad Hussain 1, Iftikhar Ali 2,, Waqar Ahmad Kaleem 3, Fatima Yasmeen 4
PMCID: PMC6572993  PMID: 31258559

Abstract

Objective:

To determine the correlation between body mass index (BMI) and lipid profile in patients with Type 2 Diabetes (T2DM) attending a tertiary care hospital in Peshawar.

Methods:

A total of 305 patients (men, 132; women, 173) with T2DM visiting an Outpatient department in Northwest General Hospital and Research Centre, Peshawar from January 2016 to July 2016 were included in this study. The whole blood and sera were analyzed for Glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TGs), high density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C). The correlation of BMI with lipid ratios and individual lipid indices were analysed.

Results:

Mean of BMI was 29.29±5.23. Dyslipidemia; increased TC, increased LDL-C, increased triglyceride and decreased HDL-C were noted in 40.7%, 54.1%, 69.5% and 41% respectively. The mean difference of LDL-C (p=0.006) was significant between male and female. BMI, TC, TGs, and LDL-C showed no significant correlation where as a significant negative correlation between BMI and HDL-C was observed (r=-0.125, p=0.029, R2=0.016). The mean values of TC, TG, LDL-C, TC/ HDL-C and LDL/HDL were greater in patients with normal BMI compared to overweight and obese; however, the differences were not significant. HDL-C differed significantly in BMI groups (p=0.040).

Conclusion:

A significant negative correlation between BMI and HDL-C was observed, while the correlation between BMI and LDL-C was observed to be insignificant. HDL-C was found significantly higher in patients with normal BMI. These results are important to indicate that there is modest impact of BMI on lipid profile. Therefore, assessment and management for altered blood lipids should not be based on a patient’s body weight or BMI.

Keywords: Lipid profile, Body mass index, Type 2 diabetes mellitus

INTRODUCTION

Diabetes is globally a fast growing public health concern, with an enormous effect on not only individuals and health care system, but also the economy of nations.1 In line with the latest information from the International Diabetes Federation, 451 million adults worldwide have diabetes; this number is predicted to touch the 693 million figure by 2045.2

Globally, Asian countries have the highest number of people with diabetes. Because of genetic variation and high vulnerability to environmental factors, classified via a low BMI, upper body high adiposity, excessive body fat proportion and a high degree of insulin resistance, the population of Asian Subcontinent faces higher risk for diabetes and its complications.3,4 BMI is frequently used to categorize individuals as underweight, normal, overweight and obese.5 It has been extensively described that BMI is a strong predictor of heart diseases and T2DM. Association of lipid profile is reported with lifestyle, intra-abdominal adiposity, obesity and BMI.6

Studies have shown a direct relationship between increasing BMI and raised TC, LDL-C, and TG and an inverse correlation with HDL-C. This correlation between BMI and lipoprotein levels, especially LDL-C, has been proposed to be a strong contributing risk factor for cardiovascular diseases in obese individual. Nevertheless, the sample size of obese and morbidly obese individuals in these studies is lacking to draw a conclusion regarding the expected lipid parameters in this population.7,8 Recently conducted observational studies validated a correlation between BMI and TG or HDL-C in obese patients, except LDL-C levels. These results have raised the question of a possible “obesity paradox” where LDL-C levels may elevate or decline with extreme BMI levels.9,10 Therefore, we sought to evaluate the correlation between body mass index and lipid profile in people with T2DM attending a tertiary care hospital in Peshawar, Pakistan.

METHODS

This cross sectional study was carried out from January 2016 to July 2016. Patients (T2DM) visiting an Outpatient department in Northwest General Hospital and Research Centre, Hayatabad, were included in the study. The hospital is a tertiary care facility, located in Peshawar. It serves patients from the whole province as well as across the border from Afghanistan. The study protocol was approved by the ethics committee of Northwest General Hospital and Research Center [Ref No. NwGH/Res/approv/9].

Blood samples (Venous) were obtained and the serum was used for analyzing HbA1c, Total cholesterol (TC), HDL-C; TG and LDL-C, using an auto analyzer (“Roche/Hitachi 912/Modular Analyzers: CAN 435”.). HbA1c was measured by “ARCHITECT c 4000 analyzer (Abbott Diagnostics)”. The National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guidelines were referred for the serum lipid reference level.11 As per the guidelines, “hypercholesterolemia is defined as TC >200 mg/dl, high LDL-C when the value is >100 mg/dl, hypertriglyceridemia when TG is >150 mg/dl and low HDL-C as a value <40 mg/dl”. “Dyslipidemia was defined as the presence of one or more abnormal serum lipid concentrations”.

Patient’s weights were taken to the nearest 0.1kg. The scale was positioned on a hard surface. The patients were then asked to wear light garment and stand in the center of the platform bare footed with their weight distributed evenly to both feet. Patients heights were measured using wall mounted stadiometer to the nearest 0.5cm. Patients were requested to stand upright with their back to the height rule. BMI was calculated as weight kg/height squared (kg/m²) and all patients according to their BMI were divided into three groups. Patients with BMI≥25kg/m² were considered obese.

Statistical analysis

SPSS Version 21.0 was used for data analysis. Pearson’s correlation was used to see various correlations. Mean comparison of different parameters was done through independent t-test and ANOVA. P-value less than 0.05 were considered statistically significant whereas value of less than 0.01 was taken highly significant. HbA1c value was measured in percentage of total hemoglobin, all other parameters values were expressed in mg/dl. All values are presented as mean ± SD or standard error of mean.

RESULTS

Of the 305 patients, 132 (43.3%) were males and 173 (56.7%) were females. Mean age (SD) was 50.19±10.16 years. The ages of the patients ranged from 17-82 years. Table-I shows that the mean (SD) of HbA1c, TC, TGs, LDL-C and HDL-C were 09.72 ± 2.62, 189.32 ± 46.68, 218.90 ± 126.24, 107.95 ± 47.10 and 52.32 ± 33.11, respectively. The age, blood lipoproteins and triglycerides, HbA1c and the BMI were stratified by gender. LDL-C differed significantly while the rest of the parameters did not show significant difference in a gender wise manner.

Table-I.

Comparison of age, BMI, HbA1c and blood lipoproteins and triglycerides among male and female patients.

Parameters Male (N=132) Female (N=173) p-value

Mean SD Range Mean SD Range
Age (years) 50.83 11.03 22-82 49.70 10.27 17-77 0.359
BMI(Kg/m2) 29.24 04.70 18-43 29.32 5.57 17-42 0.889
HbA1c (%) 09.43 02.70 5.5-17 9.91 2.53 5.5-17.1 0.112
TC(mg/dl) 184.76 42.26 94-306 192.80 49.63 96-318 0.136
TG (mg/dl) 224.05 139.53 48-1046 214.97 115.33 65-779 0.535
LDL-C (mg/dl) 99.42 47.65 20-265 114.46 45.75 43-240 0.006
HDL-C (mg/dl) 54.68 37.55 13-179 50.51 29.26 18-207 0.277
TC/HDL-C 4.43 2.09 1.33-15.38 4.37 1.36 1.32-8.35 0.744
LDL-C/HDL-C 2.59 1.51 0.18-8 2.69 1.23 0.17-5.82 0.496

The numbers and percentages of abnormal BMI, HbA1c, TC, TG, LDL-C and HDL-C were calculated to be 89.5%, 82.6%, 40.7%, 69.5%, 54.1% and 41%, respectively as shown in Table-II. Normal BMI and HbA1c were defined by World Health Organization (WHO) recommended5 Asia and Asia-pacific region cutoffs and American diabetes association (ADA)12 references correspondingly. NCEP ATP III, criteria was adapted for normal lipid ranges.11

Table-II.

Percentage of normal and abnormal BMI, HbA1c and lipid values in study sample.

Variables Normal Abnormal
BMI(Kg/m2) 32(10.5%) 273(89.5%)
HbA1c (%) 53(17.4%) 252(82.6%)
TC(mg/dl) 181(59.3%) 124(40.7%)
TG (mg/dl) 93(30.5%) 212(69.5%)
LDL-C (mg/dl) 140(45.9%) 165(54.1%)
HDL-C (mg/dl) 180(59%) 125(41%)

The percentages of normal and abnormal lipid profile in the BMI groups can be seen in Fig.1. The highest number of normal lipid parameters was observed with normal BMI, with 62.5%, 34.4%, 56.3% and 34.4% of the patients having normal values for TC, TG, LDL-C and HDL-C respectively. Similarly in obese BMI, with 62.4%, 28.3%, 46.5% and 42.9% patients having normal values for TC, TG, LDL-C and HDL-C respectively.

Fig.1.

Fig.1

Percentage of normal and abnormal lipid parameters to three BMI groups.

The Pearson’s co-efficient between the BMI and the lipid parameters obtained only one significant correlation as shown in Table-III. The BMI showed significantly negative correlation (r =-0.125, p=0.029, R2=0.016) with HDL-C value, while the others parameters like TC(r=-0.052, p=0.367, R2=0.003), TG(r=-0.006, p=0.919, R2=0.000), LDL-C(r=-0.021, p=0.721, R2=0.000), LDL-C/HDL-C (r=0.032,p=0.576, R2=0.001) and TC/HDL-C (r=0.097,p=0.091, R2=0.009) did not show any significant correlation with BMI.

Table-III.

Correlation analysis between BMI and lipid parameters.

BMI TC TG HDL-C LDL-C
TC r -0.052
p 0.367
TG r -0.006 0.343**
p 0.919 0.000
HDL-C r -0.125* 0.235** -0.064
p 0.029 0.000 0.268
LDL-C r -0.021 0.647** 0.072 -0.420**
p 0.721 0.000 0.210 0.000
LDL-C/HDL-C r 0.032 0.381** 0.197** -0.681** 0.830**
p 0.576 0.000 0.001 0.000 0.000
TC/HDL-C r 0.097 0.352** 0.358** -0.684** 0.592**
p 0.091 0.000 0.000 0.000 0.000
*

“Correlation is significant at the 0.05 level (2-tailed)”,

**

“Correlation is significant at the 0.01 level (2-tailed)”.

Patients were divided into three groups based on their body mass index (BMI); group one consisted of patients with normal BMI (≤22.9kg/m2), the group two consisted of patients with BMI value (23.0–24.9kg/m2) and group three (≥25kg/m2). Group one was noted to have higher values of TC (201.79±47.94), TG, (234.94±167.03) LDL-C (120.98±50.56), TC/HDL-C (4.61±1.87) and LDL-C/HDL-C (2.90±1.46), compared to group two and three respectively as shown in Table-IV, however the differences were not statistically significant. Moreover the mean value of HDL (66.16±45.89) was higher in patients with normal BMI; this difference across the BMI groups was statistically significant (p=0.040).

Table-IV.

Comparison of Age, HbA1c and lipid parameters with BMI groups.

Parameters Normal (N=32) Overweight (N=47) Obese (N=226) p-value

Mean SD Range SE Mean SD Range SE mean SD Range SE
Age (years) 47.28 7.76 22-65 1.37 48.49 11.82 17-82 1.72 50.95 10.61 22-77 0.706 0.091
HbA1c (%) 10.54 3.42 5.7-17.0 0.61 09.47 2.55 5.5-15.8 0.37 9.63 2.49 5.5-17.1 0.165 0.147
TC (mg/dl) 186.91 51.94 102-312 9.81 201.79 47.94 94-318 6.99 187.07 45.43 96-318 3.02 0.138
TG (mg/dl) 203.56 113.74 62-538 20.11 234.94 167.03 58-779 24.36 217.73 118.13 48-1046 7.86 0.537
LDL-C (mg/dl) 99.13 53.16 33-218 9.40 120.98 50.56 30-265 7.37 106.50 45.130 20-229 3.002 0.084
HDL-C (mg/dl) 66.16 45.89 26-179 8.11 52.36 28.58 20-165 4.17 50.35 31.51 13-207 2.096 0.040
TC/HDL-C 3.72 1.85 1.40-7.26 0.33 4.61 1.87 1.33-8.35 0.27 4.45 1.78 1.32-15-38 0.118 0.070
LDL-C/HDL-C 2.28 1.62 0.25-4.81 0.286 2.90 1.46 0.18-5.19 0.214 2.64 1.29 0.17-8.00 0.086 0.139

SE; standard error. Group-1: Normal BMI; Group-2: Overweight BMI; Group-3: Obese BMI.

DISCUSSION

Research literature support a relationship between BMI and TG, and the relationship of blood lipids and body fat distribution has been under discussion over the past few decades.3,13 Body fat and blood lipids have been observed to be key determinants of metabolic disorders, like cardiovascular diseases (CVD), diabetes, dyslipidemia, hypertension, hyperinsulinemia and elevated serum uric acid.14,15

Dyslipidemia, a well known risk factor for cardiovascular manifestations, is mostly observed in the population of the Asian continent. People with T2DM have an increased cardiovascular morbidity and mortality, and are affected more by CVD compared with non diabetics. Prompt recognition and management of DM associated dyslipidemia might be one step in controlling the risk of CVD.3,15,16

Obesity, which is considered to be potentially linked with abnormal lipids and poor cardiovascular outcomes, is becoming a highly prevalent condition in Pakistan.17 The current study intends to evaluate the correlation between BMI and lipids in patients with T2DM in a Khyber Pakhtunkhwa population; an area from where information in this regard is up till now not available.

In this study, 305 diabetic patients attending the outpatient department (diabetic clinic) at the Northwest General Hospital and Research Centre, Peshawar were randomly selected for the study. The participants were already diagnosed as having T2DM and were under treatment at the diabetic clinic. The patients included 132 (43.3%) men and 173 (57.7%) women. The female population was more than that of the male counterpart. This compares well with a study on WHO global data which stated that the prevalence ratio of DM between men and women varies markedly, with no consistent trend.18

Age, BMI, HbA1c and lipids values were stratified in gender wise manner; in male patients mean values of BMI and TC were slightly lower and that of TG and HDL-C were higher compared to female patients but the mean differences were not statistically significant which is consistent with previous studies results in TG15 and TC.6 However the mean difference of LDL-C in male and female patients was statistically significant. This is in agreement to the findings of a study which showed similar result in LDL-C values between men and women, although the mean values of TG and HDL-C were differ significantly whereas TC was comparable in both genders.19 In a study by Omotoye FE et al. which showed that mean TC, TG, and LDL-C were elevated more among the T2DM female patients than males.6

Following the WHO, ADA and NCEP ATP III criteria for BMI, HbA1c and Lipid profile values. The most common lipid abnormality was seen in TGs with 69% of the study participants, followed by the LDL-C(54.1%). This result is in agreement with published studies in Northwest Ethiopia (63.5%), Hyderabad-India (60%) and Sudan (48.8%).20 These findings may be due to the increased secretion of LDL-C by the liver and slow removal of TGs rich lipoproteins, as well as raised levels of substrates for TG production from augmented mobilization of free fatty acid (FFA) from adipose tissue in people with diabetes.21 High TG levels are a prominent lipid abnormality in T2DM and also occur in individuals with pre-diabetes states. A fasting TG level of >150 mg/dl is one of the benchmark for characterizing peoples at high risk for CVD and T2DM. Our results showed raised LDL-C and low HDL-C levels in DM patients. These results are in agreement to Asian Pacific Cohort Studies Collaboration.22 These findings are thought to be due to differences in genetic makeup, differences in life style and the management of specific population of DM being studied.

This study showed that in the study population mean BMI was not different in males and females (29.24 vs. 29.32) kg/m2. These BMI results were higher than the previously published mean BMI of participants from an urban community in Yemen (23.9 ± 5.1) kg/m2 and 21.8 ±8.9) kg/m2 in females and males, respectively23 and also the work of Al-Sharafi which showed that the overall mean BMI was considerably higher in females than in males (28 vs. 25.4).24

In our study two patients were underweight (17.5 kg/m2) which was considered normal. Whereas, 10.5% were normal weight, 15.4% were overweight and obese (BMI>25) accounted for 74.1% of the total investigated population with diabetes mellitus. This figure was lower than that of a study by Bansal P et al.25 but higher than the findings of a previous study in Yemen that overweight and obesity accounted only for 26.2% of patients with T2DM aged 20-65.24 The international data Analysis with reference to the relationship between BMI and both morbidity and mortality recommended that the association of BMI with most diseases was rather continuous26 and commonly, women had a higher mean BMI than men.27 With regards to relationship between BMI and lipid profile this study showed that BMI had a negative correlation (r =-0.125, p=0.029) with HDL-C value while the others parameters like TC(r=-0.052, p=0.367), TG(r=-0.006, p=0.919), LDL-C(r=-0.021, p=0.721) did not reveal any correlation with BMI.Our results are different from other similar studies. Results of a study conducted in Korea described that there was a positive correlation between BMI with TC and LDL-C respectively; whereas a study from India illustrated the existence of only BMI vs. LDL-C correlation.28,29 A weak negative correlation of HDL-C with BMI was also reported by a similar study conducted in Nigeria.6 Likewise in a study by Shamai et al there was an association between BMI, HDL-C and TG.7

In this study T2DM patient with normal BMI when compared to overweight and obese BMI did not show significant differences in the mean values of TC, TGs and LDL-C except HDLC. In a study by Yadav NK et al., reported that obese T2DM patients, in comparison with on-diabetic obese control patients revealed statistically significant increase in the levels of TC, TGs, LDL-C whereas HDL-C levels in the two groups did not show statistically significant difference.30 Another study on Iraqi diabetic premenopausal women showed that high BMI is consistently coupled with abnormal lipid profile marked by elevated TGs and LDL-C, and low HDL-C.13 Comparison of HDL-C levels showed that Group one individuals had the most favourable values (66.16 ± 45.90). This was followed by individuals in Group two (52.36 ± 28.58) and Group three (50.35 ± 31.51). This difference in HDL-C levels across the three groups was significant (p < 0.040). Our results are consistent with a study by Bora K et al.31

Both body fat and lipid parameters have been revealed to be the significant predictors for metabolic disturbances including diabetes, dyslipidaemia, hypertension, hyperinsulinaemia, and cardiovascular diseases. Lipid profiles association is reported with lifestyle, age, intra-abdominal adiposity, Obesity and BMI.6

Limitations of the study

The contribution of diet and socio-economic factors in influencing lipid profile and obesity were not considered. In addition, a randomly drawn larger sample would have been more advantageous. Constraint resources and lack of time was the chief causes for these limitations. Similarly waist circumference (WC) was not measured.

CONCLUSION

This study showed high percentage of abnormal TG. LDL-C level was observed to be significantly higher in female. A significant negative relationship between HDL-C and BMI level was also seen, while the correlation between LDL-C and BMI was observed to be insignificant. HDL-C was found significantly higher in patients with normal BMI. These results are imperative as they back up that there is modest impact of BMI on lipid profile. Diabetic patients are more likely to have dyslipidemia which is a key determinant for atherosclerosis and CVD. Normal BMI significantly improves dyslipidemia in T2DM patients. Further studies with large sample size are needed to identify the causes of obesity that would help in better understanding of its influence on lipid profile.

Authors’ Contributions

AH and IA: Conception & design.

AH: Data collection.

AI: Data analysis and interpretation/results.

AI, WAK and FY: Manuscript drafting and writing.

AH, IA and FY: Language editing/appropriateness, critical revision.

All authors have read and approved the final version of the paper.

Footnotes

Grant support and financial disclosure: None.

REFERENCES

  • 1.Hussain A, Ali I. Diabetes mellitus in Pakistan:A major public health concern. Arch Pharm Pract. 2016;7(1):30–32. doi:10.4103/2045-080X.174943. [Google Scholar]
  • 2.Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A, et al. IDF Diabetes Atlas:global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 2018;138:271–281. doi: 10.1016/j.diabres.2018.02.023. doi:10.1016/j.diabres.2018.02.023. [DOI] [PubMed] [Google Scholar]
  • 3.Arora M, Koley S, Gupta S, Sandhu J. A study on lipid profile and body fat in patients with diabetes mellitus. Anthropologist. 2007;9(4):295–298. doi:10.1080/09720073.2007.11891015. [Google Scholar]
  • 4.Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012;3(6):110. doi: 10.4239/wjd.v3.i6.110. doi:10.4239/wjd.v3.i6.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull World Health Organ. 1986;64(6):929. [PMC free article] [PubMed] [Google Scholar]
  • 6.Omotoye FE, Fadupin GT. Effect of body mass index on lipid profile of type 2 Diabetic patients at an urban tertiary hospital in Nigeria. IOSR-JDMS. 2016;15(9):65–70. doi:10.9790/0853-1509086570. [Google Scholar]
  • 7.Shamai L, Lurix E, Shen M, Novaro GM, Szomstein S, Rosenthal R, et al. Association of body mass index and lipid profiles:evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obes. Surg. 2011;21(1):42–47. doi: 10.1007/s11695-010-0170-7. doi:10.1007/s11695-010-0170-7. [DOI] [PubMed] [Google Scholar]
  • 8.Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Hazen SL, Ntanios F, et al. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study) Am J Cardiol. 2006;97(11):1553–1557. doi: 10.1016/j.amjcard.2005.12.042. doi:10.1016/j.amjcard.2005.12.042. [DOI] [PubMed] [Google Scholar]
  • 9.McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA. 2006;296(1):79–86. doi: 10.1001/jama.296.1.79. doi:10.1001/jama.296.1.79. [DOI] [PubMed] [Google Scholar]
  • 10.Drapeau V, Lemieux I, Richard D, Bergeron J, Tremblay A, Biron S, et al. Metabolic profile in severely obese women is less deteriorated than expected when compared to moderately obese women. Obes Surg. 2006;16(4):501–509. doi: 10.1381/096089206776327215. doi:10.1381/096089206776327215. [DOI] [PubMed] [Google Scholar]
  • 11.Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486. doi:10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
  • 12.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–S69. doi: 10.2337/dc10-S062. doi:10.2337/dc10-S062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ali ZAUA, Al-Zaidi MS. The association between body mass index, lipid profile and serum estradiol levels in a sample of irAqi diabetic premenopausal women. Oman Med J. 2011;26(4):263–266. doi: 10.5001/omj.2011.63. doi:10.5001/omj.2011.63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. J Diabetes Metab Disord. 2014;13(1):58. doi: 10.1186/2251-6581-13-58. doi:10.1186/2251-6581-13-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hussain A, Ali I, Ijaz M, Rahim A. Correlation between hemoglobin A1c and serum lipid profile in Afghani patients with type 2 diabetes:hemoglobin A1c prognosticates dyslipidemia. Ther Adv Endocrinol Metab. 2017;8(4):51–57. doi: 10.1177/2042018817692296. doi:10.1177/2042018817692296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults:the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413–420. doi: 10.7326/0003-4819-141-6-200409210-00006. doi:10.7326/0003-4819-141-6-200409210-00006. [DOI] [PubMed] [Google Scholar]
  • 17.Tanzil S, Jamali T. Obesity, an emerging epidemic in Pakistan-a review of evidence. J Ayub Med Coll Abbottabad. 2016;28(3):597. [PubMed] [Google Scholar]
  • 18.Amoako G. Association between glycaemic control and lipid profile among type 2 diabetes patients:glycated haemoglobin as a dual marker. Ghana: Kwame Nkrumah University of Science and Technology Kumasi 2015; [Google Scholar]
  • 19.Ni W-Q, Liu X-L, Zhuo Z-P, Yuan X-L, Song J-P, Chi H-S, et al. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis. 2015;14(1):71. doi: 10.1186/s12944-015-0073-7. doi:10.1186/s12944-015-0073-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Biadgo B, Abebe SM, Baynes HW, Yesuf M, Alemu A, Abebe M. Correlation between serum lipid profile with anthropometric and clinical variables in patients with type 2 diabetes mellitus. Ethiop J Health Sci. 2017;27(3):215–226. doi: 10.4314/ejhs.v27i3.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009;5(3):150. doi: 10.1038/ncpendmet1066. doi:10.1038/ncpendmet1066. [DOI] [PubMed] [Google Scholar]
  • 22.Asia Pacific Cohort Studies Collaboration. Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region. Diabetologia. 2007;50(11):2289–2297. doi: 10.1007/s00125-007-0801-2. doi:10.1007/s00125-007-0801-2. [DOI] [PubMed] [Google Scholar]
  • 23.Gunaid A. Obesity, overweight and underweight among adults in an urban community in Yemen. East Mediterr Health J. 2012;18(12):1187–1193. doi: 10.26719/2012.18.12.1187. [DOI] [PubMed] [Google Scholar]
  • 24.Al-Sharafi BA, Gunaid AA. Prevalence of obesity in patients with type 2 diabetes mellitus in Yemen. Int J Endocrinol Metab. 2014;12(2):e13633. doi: 10.5812/ijem.13633. doi:10.5812/ijem.13633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bansal P, Upadhyay HP. Correlation between Body Mass Index and Serum Lipid Profile in a Diabetic population of central Nepal. JCMS Nepal. 2018;14(4):184–188. doi:10.3126/jcmsn.v14i4.21997. [Google Scholar]
  • 26.Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980:systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–567. doi: 10.1016/S0140-6736(10)62037-5. doi:10.1016/S0140-6736(10)62037-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ezzati M, Lopez AD, Rodgers A, Murray CJ. Comparative quantification of health risks:global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. [Google Scholar]
  • 28.Choi S, Tan E. Anthropometric measures and lipid CHD risk factors in Korean Immigrants with Type 2 Diabetes. J Cardiovasc Nurs. 2011;26(5):414–422. doi: 10.1097/JCN.0b013e3182017c1f. doi:10.1097/JCN.0b013e3182017c1f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Himabindu Y, Sriharibabu M, Alekhya K, Saisumanth K, Lakshmanrao N, Komali K. Correlations between anthropometry and lipid profile in type 2 diabetics. Indian J Endocrinol Metab. 2013;17(4):727–729. doi: 10.4103/2230-8210.113769. doi:10.4103/2230-8210.113769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yadav NK, Thanpari C, Shrewastwa M, Mittal R. Comparison of lipid profile in type-2 obese diabetics and obese non-diabetic individuals. A hospital based study from Western Nepal. Kathmandu Univ Med J. 2012;39(3):44–47. doi: 10.3126/kumj.v10i3.8017. [DOI] [PubMed] [Google Scholar]
  • 31.Bora K, Pathak MS, Borah P, Das D. Variation in lipid profile across different patterns of obesity–Observations from Guwahati, Assam. J Clin Diagn Res. 2015;9(11):OC17–OC21. doi: 10.7860/JCDR/2015/15334.6787. doi:10.7860/JCDR/2015/15334.6787. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pakistan Journal of Medical Sciences are provided here courtesy of Professional Medical Publications

RESOURCES